appendix 4c - quarterly, page-4

This quarterly is fine, and should mark the low point. Cash outflow, ex USA, will reduce going forward, R&D tax credit of $4.8m, first benefits of restructuring, and more to come if R&D outsourced.

The Investor Briefing provides a more positive story than the bare numbers are telling.

There are good raesons why it's not $3, or even $1.35 anymore, but, down at 13c, the baby has well and truly been thrown out with the bathwater.

Positive announceemnts in Q4 should take this stock back to 40c without any trouble, IMO.